[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"chronic-leg-ulcer\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:chronic-leg-ulcer":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100615585","early-phase-1-efficacy-of-platelet-rich-fibrin-gel-in-patients-with-chronic-leg-ulcers-100615585",false,"NCT07294521","Efficacy of Platelet-rich-Fibrin Gel in Patients With Chronic Leg Ulcers","Inclusion Criteria:\n\n* All male and female patients more than 35 years old with Chronic Leg Ulcers, presenting to the OPD will be included.\n\nExclusion Criteria:\n\n* Patients with clinical signs of infected ulcers, patients in sepsis and immunosuppressed individuals will be excluded.",true,"ALL","35 Years",{"count":19,"type":20},40,"ESTIMATED","INTERVENTIONAL",[23],"EARLY_PHASE1","Platelet rich Fibrin (PRF) gel is an emerging as a novel treatment option for chronic leg ulcers and has the potential to become the 1st line option in these conditions. The objective of our study will be to assess the efficacy of PRF gel dressing in patients with non-infective chronic leg ulcers.",[26],"Chronic Leg Ulcer",[28,29],"Chronic leg ulcer","Platelet rich fibrin","RECRUITING","2026-03-09",{"date":33,"type":34},"2026-03-11","ACTUAL",{"date":36,"type":34},"2025-12-16",{"date":38,"type":20},"2026-05-12",{"name":40,"class":41},"Pak Emirates Military Hospital","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":16,"minAge":49,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":21,"phases":52,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":42},"100471697","oxygen-wound-therapy-feasibility-study-100471697","NCT05422248","Oxygen Wound Therapy Feasibility Study","Inclusion Criteria:\n\n* Patients with hard to heal lower leg wounds as determined by the treating clinician.\n* Patient has a wound area greater than the area of the interface\n* Aged 16 years and over\n* Able to provide informed consent\n\nExclusion Criteria:\n\n* Lower limb wounds with bone or tendon exposed\n* Infected wounds which require treatment with antibiotics\n* Wounds with critical bioburden requiring a medicated dressing\n* Wounds that require dressing changes more than every second day, for example high exudating wounds\n* Wounds with slough covering more than 30% of the wound surface","16 Years",{"count":51,"type":20},10,[53],"NA","Determine the feasibility of using a new topical oxygen therapy device to treat hard to heal lower leg wounds.",[26],"2023-09-11",{"date":58,"type":34},"2023-09-13",{"date":60,"type":34},"2022-12-01",{"date":62,"type":20},"2026-08-01",{"name":64,"class":65},"Fisher and Paykel Healthcare","INDUSTRY"]